Anti-evolvability drugs could slow antibiotic resistance in bacteria

Researchers found that one mechanism by which antibiotics induce drug-resistance mutations in bacteria is by triggering the generation of high levels of toxic molecules called reactive oxygen species (ROS). Additionally, treatment with a ROS-reducing drug approved by the US Food and Drug Administration for other purposes prevented these antibiotic-induced mutations.

Article: ScienceDaily

Smart Innovations  

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed